169 related articles for article (PubMed ID: 38124067)
1. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.
Leiva MC; Gustafsson A; Garre E; Ståhlberg A; Kovács A; Helou K; Landberg G
J Transl Med; 2023 Dec; 21(1):924. PubMed ID: 38124067
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.
Leiva MC; Garre E; Gustafsson A; Svanström A; Bogestål Y; Håkansson J; Ståhlberg A; Landberg G
J Cell Physiol; 2021 Jun; 236(6):4709-4724. PubMed ID: 33368325
[TBL] [Abstract][Full Text] [Related]
3. 5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information.
Salerno S; Ståhlberg A; Holdfeldt A; Bexe Lindskog E; Landberg G
J Transl Med; 2022 May; 20(1):209. PubMed ID: 35562738
[TBL] [Abstract][Full Text] [Related]
4. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery.
Svanström A; Rosendahl J; Salerno S; Leiva MC; Gregersson P; Berglin M; Bogestål Y; Lausmaa J; Oko A; Chinga-Carrasco G; Petronis S; Standoft S; Ståhlberg A; Håkansson J; Landberg G
Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34030145
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment.
Landberg G; Fitzpatrick P; Isakson P; Jonasson E; Karlsson J; Larsson E; Svanström A; Rafnsdottir S; Persson E; Gustafsson A; Andersson D; Rosendahl J; Petronis S; Ranji P; Gregersson P; Magnusson Y; Håkansson J; Ståhlberg A
Biomaterials; 2020 Mar; 235():119705. PubMed ID: 31978840
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes.
Persson E; Gregersson P; Gustafsson A; Fitzpatrick P; Rhost S; Ståhlberg A; Landberg G
Cell Commun Signal; 2021 Jun; 19(1):66. PubMed ID: 34090457
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Patient-Derived Scaffolds Can Expose Unique Individual Cancer Progressing Properties of the Cancer Microenvironment Associated with Clinical Characteristics.
Garre E; Gustafsson A; Leiva MC; Håkansson J; Ståhlberg A; Kovács A; Landberg G
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565301
[TBL] [Abstract][Full Text] [Related]
8. Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP).
Lehuédé C; Li X; Dauvillier S; Vaysse C; Franchet C; Clement E; Esteve D; Longué M; Chaltiel L; Le Gonidec S; Lazar I; Geneste A; Dumontet C; Valet P; Nieto L; Fallone F; Muller C
Breast Cancer Res; 2019 Jan; 21(1):7. PubMed ID: 30654824
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.
Hu K; Law JH; Fotovati A; Dunn SE
Breast Cancer Res; 2012 Feb; 14(1):R22. PubMed ID: 22309939
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer.
Gustafsson A; Garre E; Leiva MC; Salerno S; Ståhlberg A; Landberg G
Sci Rep; 2021 Jun; 11(1):13334. PubMed ID: 34172801
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer.
Liang Y; Li Y; Song X; Zhang N; Sang Y; Zhang H; Liu Y; Chen B; Zhao W; Wang L; Guo R; Yu Z; Yang Q
Cancer Biol Ther; 2018 Feb; 19(2):120-131. PubMed ID: 29293402
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived scaffolds as a model of colorectal cancer.
Parkinson GT; Salerno S; Ranji P; Håkansson J; Bogestål Y; Wettergren Y; Ståhlberg A; Bexe Lindskog E; Landberg G
Cancer Med; 2021 Feb; 10(3):867-882. PubMed ID: 33356003
[TBL] [Abstract][Full Text] [Related]
13. Cell-type-specific responses to chemotherapeutics in breast cancer.
Troester MA; Hoadley KA; Sørlie T; Herbert BS; Børresen-Dale AL; Lønning PE; Shay JW; Kaufmann WK; Perou CM
Cancer Res; 2004 Jun; 64(12):4218-26. PubMed ID: 15205334
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group.
Martin M; Villar A; Sole-Calvo A; Gonzalez R; Massuti B; Lizon J; Camps C; Carrato A; Casado A; Candel MT; Albanell J; Aranda J; Munarriz B; Campbell J; Diaz-Rubio E;
Ann Oncol; 2003 Jun; 14(6):833-42. PubMed ID: 12796019
[TBL] [Abstract][Full Text] [Related]
15. Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines.
Troester MA; Hoadley KA; Parker JS; Perou CM
Environ Health Perspect; 2004 Nov; 112(16):1607-13. PubMed ID: 15598611
[TBL] [Abstract][Full Text] [Related]
16. Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer.
Tato-Costa J; Casimiro S; Pacheco T; Pires R; Fernandes A; Alho I; Pereira P; Costa P; Castelo HB; Ferreira J; Costa L
Clin Colorectal Cancer; 2016 Jun; 15(2):170-178.e3. PubMed ID: 26603055
[TBL] [Abstract][Full Text] [Related]
17. Single drug biomarker prediction for ER- breast cancer outcome from chemotherapy.
Chen YZ; Kim Y; Soliman HH; Ying G; Lee JK
Endocr Relat Cancer; 2018 Jun; 25(6):595-605. PubMed ID: 29599124
[TBL] [Abstract][Full Text] [Related]
18. Conditionally replicative adenovirus-based mda-7/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin.
Xu J; Mo Y; Wang X; Liu J; Zhang X; Wang J; Hu L; Yang C; Chen L; Wang Y
J Gastroenterol; 2013 Feb; 48(2):203-13. PubMed ID: 22820863
[TBL] [Abstract][Full Text] [Related]
19. A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer model.
Pritchard JE; Dillon PM; Conaway MR; Silva CM; Parsons SJ
Oncology; 2012; 83(6):305-20. PubMed ID: 22964943
[TBL] [Abstract][Full Text] [Related]
20. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
